IL11 and fatty liver disease: developed a neutralizing anti-IL-11 antibody and a neutralizing anti-IL-11 receptor α (IL-11RA) antibody, and found that they significantly alleviated the hepatic steatosis, liver inflammation, and hepatic fibrosis in MASH mice by inhibiting the activation of HSCs by IL-11 (177).